Interested in the future of nanomedicine within continuous manufacturing? 💡 We’re excited to share insights from the FDA and University of Connecticut’s recent R&D. Their findings showcase the #NanoFlowSizer as a revolutionary tool for enabling real-time, non-invasive monitoring and control of nanoparticle formation. As a key PAT tool, the NanoFlowSizer is setting new benchmarks for precision and efficiency in nanomedicine production, from liposomes to lipid nanoparticles. Want to learn more about how this technology is shaping the future of pharma innovation? Check out the original post by InProcess-LSP below! 👇 For more information or to request a quote on the NanoFlowSizer, visit our website: https://lnkd.in/dpumbkUS #Nanomedicine #ContinuousManufacturing #PharmaInnovation #Liposomes
🌟 Exciting News in Continuous Manufacturing of nanomedicine! 🌟 A recent poster of R&D by the FDA and University of Connecticut shows how inline integration of the #NanoFlowSizer in a continuous process enables monitoring and control of nanoparticle formation and faster development of a design space for future drug products. NanoFlowSizer systems are capable of analyzing nanoparticles continuously and non-invasively in any transparent container, and during flow, making them unique as #PAT tool for #nanomedicine production processes. #ContinuousManufacturing #PharmaInnovation #Liposomes #LipidNanoparticles #ProcessAnalytics